Nutrition Research
Volume 29, Issue 9 , Pages 609-615 , September 2009

Krill oil supplementation increases plasma concentrations of eicosapentaenoic and docosahexaenoic acids in overweight and obese men and women

  • Kevin C. Maki

      Affiliations

    • Provident Clinical Research, Bloomington, IN 47403, USA
    • Provident Clinical Research, Glen Ellyn, IL 60137, USA
    • Corresponding Author InformationCorresponding author. Provident Clinical Research, Glen Ellyn, IL 60137, USA. Tel.: +1 630 858 4400; fax: +1 630 858 4490.
    • ,
  • Mathew S. Reeves

      Affiliations

    • Provident Clinical Research, Bloomington, IN 47403, USA
    • Provident Clinical Research, Glen Ellyn, IL 60137, USA
    • ,
  • Mildred Farmer

      Affiliations

    • Meridien Research, St. Petersburg, FL 33709, USA
    • ,
  • Mikko Griinari

      Affiliations

    • Clanet Ltd, 02660 Espoo, Finland
    • ,
  • Kjetil Berge

      Affiliations

    • Aker BioMarine ASA, PO Box 1423 Vika, NO-0115 Oslo, Norway
    • ,
  • Hogne Vik

      Affiliations

    • Aker BioMarine ASA, PO Box 1423 Vika, NO-0115 Oslo, Norway
    • ,
  • Rachel Hubacher

      Affiliations

    • Provident Clinical Research, Bloomington, IN 47403, USA
    • Provident Clinical Research, Glen Ellyn, IL 60137, USA
    • ,
  • Tia M. Rains

      Affiliations

    • Provident Clinical Research, Bloomington, IN 47403, USA
    • Provident Clinical Research, Glen Ellyn, IL 60137, USA

Received 27 August 2009 ,Revised 11 September 2009 ,Accepted 11 September 2009.

References 

  1. Eslick GD, Howe PR, Smith C, Priest R, Bensoussan A. Benefits of fish oil supplementation in hyperlipidemia: a systematic review and meta-analysis. Int J Cardiol. 2009;136:4–16
  2. Hu FB, Manson JE, Willett WC. Types of dietary fat and risk of coronary heart disease: a critical review. J Am Coll Nutr. 2001;20:5–19
  3. Kris-Etherton PM, Harris WS, Appel LJ for the Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 2002;106:2747–2757
  4. Harris WS, Kris-Etherton PM, Harris KA. Intakes of long-chain omega-3 fatty acid associated with reduced risk for death from coronary heart disease in healthy adults. Curr Atheroscler Rep. 2008;10:503–509
  5. GISSI Investigators . Dietary supplementation with n-3 poly-unsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet. 1999;354:447–455
  6. Breslow J. N-3 fatty acids and cardiovascular disease. Am J Clin Nutr. 2006;83(suppl):1477S–1482S
  7. Leaf A, Xiao YF, Kang JX, et al. Prevention of sudden cardiac death by ω-3 polyunsaturated fatty acids. Pharmacol Ther. 2003;98:355–377
  8. Davidson MH, Stein EA, Bays HE, et al. Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study. Clin Ther. 2007;29:1354–1367
  9. Maki KC, McKenney JM, Reeves MS, Lubin BC, Dicklin MR. Effects of adding prescription omega-3 acid ethyl esters to simvastatin (20 mg/day) on lipids and lipoprotein particles in men and women with mixed dyslipidemia. Am J Cardiol. 2008;102:429–433
  10. Harris WS, Zucker ML, Dujovne CA. Omega-3 fatty acids in hypertriglyceridemic patients: triglycerides vs methyl esters. Am J Clin Nutr. 1988;48:992–997
  11. Mozaffarian D, Lemaitre R, Kuller L, Burke G, Tracy R, Siscovick D. Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the Cardiovascular Health Study. Circulation. 2003;107:1372–1377
  12. Buemann B, Toubro S, Raben A, Astruo A. Human tolerance to a single, high dose of d-tagatose. Regul Toxicol Pharmacol. 1999;29:S66–S70
  13. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502
  14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419
  15. American Oil Chemist Society . Fatty acid composition by GLC: marine oils. Method Ce 1b-89. Official Methods and Recommended Practices of the American Oil Chemist Society, 5th ed. Champaign, IL: AOCS Press; 1998;
  16. Nyyssönen K, Kaikkonen J, Salonen JT. Characterization and determinants of an electronegatively charged low-density lipoprotein in human plasma. Scand J Clin Lab Invest. 1996;56:681–689
  17. Walter MF, Blumberg JB, Dolnikowski GG, Handelman GJ. Streamlined F2-isoprostane analysis in plasma and urine with high-performance liquid chromatography and gas chromatography/mass spectroscopy. Anal Biochem. 2000;280:73–79
  18. Harris WS. Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. J Lipid Res. 1989;30:785–807
  19. Harris WS. n-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr. 1997;65:1645S–1654S
  20. Fekete K, Marosvolgyi T, Jakobik V, Decsi T. Methods of assessment of n-3 long chain polyunsaturated fatty acid status in humans: a systematic review. Am J Clin Nutr. 2009;89:2070S–2084S
  21. Geleijnse JM, Giltay EJ, Grobbee DE, Donders AR, Kok FJ. Blood pressure response to fish oil supplementation: meta-regression analysis of randomized trials. J Hypertens. 2002;20:1493–1499
  22. Jacobson TA. Role of n-3 fatty acids in the treatment of hypertriglyceridemia and cardiovascular disease. Am J Clin Nutr. 2008;87:1981S–1990S
  23. Calder PC. Polyunsaturated fatty acids, inflammation, and immunity. Lipids. 2001;36:1007–1024
  24. Madsen T, Christensen JH, Blom M, Schmidt EB. The effect of dietary n-3 fatty acids on serum concentrations of C-reactive protein: a dose-response study. Br J Nutr. 2003;894:517–522
  25. Geelen A, Brouwer IA, Schouten EG, Kluft C, Katan MB, Zock PL. Intake of n-3 fatty acids from fish does not lower serum concentrations of C-reactive protein in healthy subjects. Eur J Clin Nutr. 2004;58:1440–1442
  26. Davidson MH, Maki KC, Bays H, Carter R, Ballantyne CM. Effects of prescription omega-3-acid ethyl esters on lipoprotein particles in statin-treated subjects with hypertriglyceridemia. J Clin Lipidol. 2009;[epub ahead of press, Sept. 2009]
  27. De Luis DA, Conde R, Aller R, Izaola O, González Sagrado M, Perez Castrillón JL, et al. Effect of omega-3 fatty acids on cardiovascular risk factors in patients with type 2 diabetes mellitus and hypertriglyceridemia: an open study. Eur Rev Med Pharmacol Sci. 2009;13:51–55
  28. Deveraj S, Hirany SV, Burk RF, Jialal I. Divergence between LDL oxidative susceptibility and urinary F-2 isoprostanes as measure of oxidative stress in type 2 diabetes. Clin Chem. 2001;47:1974–1979
  29. Cao J, Schwichtenberg KA, Hanson NQ, Tsai MY. Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids. Clin Chem. 2006;52:2265–2272

PII: S0271-5317(09)00161-4

doi: 10.1016/j.nutres.2009.09.004

Nutrition Research
Volume 29, Issue 9 , Pages 609-615 , September 2009

Article Tools

* Image Usage & Resolution